| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 05/28/2009 | US20090137021 Anti-inflammatory medicaments |
| 05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
| 05/28/2009 | US20090136473 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | US20090133318 Anthranilamide insecticides |
| 05/28/2009 | CA2722611A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | CA2722582A1 Biaryl pde4 inhibitors for treating inflammation |
| 05/27/2009 | EP2061783A2 Improved process for rimonabant |
| 05/27/2009 | EP2061766A2 Novel compounds |
| 05/27/2009 | EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders |
| 05/27/2009 | EP2061751A1 Nitrate esters of aminoalcohols |
| 05/27/2009 | EP2061449A1 Substituted acetylenic compounds useful for the treatment of diseases |
| 05/27/2009 | EP1742923B1 Pyrazole phenyl derivatives as ppar activators |
| 05/27/2009 | EP1730141B1 Compounds for the treatment of diseases |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | CN101443316A 1,5-diphenylpyrazoles II as HSP90 inhibitors |
| 05/27/2009 | CN101440065A Mechanochemical preparation of 1,3,5-triaryl-2-pyrazoline compounds |
| 05/27/2009 | CN100491373C Photochromic thiophene pyrazole heterocyclic mixed linkage type asymmetrical dithienylethene compounds, and their preparing method and use |
| 05/27/2009 | CN100491356C Compounds exhibiting thrombopoietin receptor agaonism |
| 05/27/2009 | CN100491355C Cyclic diamine compound having five-membered cyclic group |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538134 1-aryl-4-cyclopropylpyrazoles with at least one fluorine attached to the cyclopropyl ring; parasiticides; fleas; Extended duration of action for at least 28 days |
| 05/26/2009 | US7538073 For controlling undesirable microorganisms |
| 05/22/2009 | WO2009064251A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | WO2009064250A1 Bis-(sulfonylamino) derivatives in therapy 065 |
| 05/22/2009 | WO2009063953A1 Phenylpyrazole derivatives |
| 05/22/2009 | WO2008043567A8 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 05/22/2009 | CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | CA2705502A1 Phenylpyrazole derivatives |
| 05/21/2009 | US20090131662 Compositions And Methods Pertaining To PNA Synthons And Oligomers Comprising A Universal Base |
| 05/21/2009 | US20090131435 Heterocyclic inhibitors of mek and methods of use |
| 05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
| 05/21/2009 | US20090131413 Thienopyrazole Derivative Having PDE7 Inhibitory Activity |
| 05/21/2009 | US20090131256 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane Compounds |
| 05/20/2009 | CN101437778A Reaction reagent for trifluoromethylation |
| 05/19/2009 | US7534894 2-[(4'-{[5-(2-chlorophenyl)-2-(trifluoromethyl)-3-furoyl]amino}-1,1'-biphenyl-3-yl)oxy]-3-phenylpropanoic acid ; thrombosis, atrial fibrillation, pulmonary fibrosis, stroke, myocardial ischemia, atherosclerotic plaque formation, chronic obstructive pulmonary disease, or renal fibrosis |
| 05/19/2009 | US7534273 Such as 2-(4-{[4-(dimethylamino)-phenyl]methylidene}-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)-3-methyl-1,3-benzothiazol-3-ium methylsulfate; operating as gentle nonoxidative direct dyes |
| 05/14/2009 | WO2009061652A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | WO2009061596A1 Compounds for inhibiting ksp kinesin activity |
| 05/14/2009 | WO2009060232A1 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid - 465 |
| 05/14/2009 | WO2009027601A3 Pyrazole 3,5 carboxylate derivatives preparation and therapeutic application thereof |
| 05/14/2009 | US20090124816 Crystalline Chemotherapeutic |
| 05/14/2009 | US20090124815 Crystalline Chemotherapeutic |
| 05/14/2009 | US20090124621 Pyrazole derivatives as kinase inhibitors |
| 05/14/2009 | US20090124607 Novel Bicyclic Sulfonamides for Use as Glucocorticoid Receptor Modulators in the Treatment of Inflammatory Diseases |
| 05/14/2009 | CA2704684A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | CA2703781A1 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid - 465 |
| 05/14/2009 | CA2702990A1 Compounds for inhibiting ksp kinesin activity |
| 05/13/2009 | EP2057144A2 Novel polymorphs of rimonabant |
| 05/13/2009 | EP2057126A2 Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives |
| 05/13/2009 | EP2057125A1 Non-nucleoside reverse transcriptase inhibitors |
| 05/13/2009 | EP2057124A2 Compounds and compositions as itpkb inhibitors |
| 05/13/2009 | EP2057116A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/13/2009 | EP1565429B1 Diaryl ureido derivatives and their medical use |
| 05/13/2009 | CN101432269A 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| 05/13/2009 | CN101429163A Recovery processing method for waste material in pyrazolone production |
| 05/13/2009 | CN101429162A Method for producing 1-phenyl-3,5-di-substituted aryl-2-pyrazoline |
| 05/13/2009 | CN100486975C Novel anthranilamide insecticides |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/12/2009 | US7531669 Methods for treating neural disorders and conditions, and compounds useful therefor |
| 05/12/2009 | US7531566 Anti-inflammatory medicaments |
| 05/12/2009 | CA2367984C Synergistic insecticidal compositions |
| 05/07/2009 | WO2009055917A1 Inhibitors of histone deacetylase |
| 05/07/2009 | WO2009038411A3 Beta-secretase inhibiting compounds having oxo-dihydro-pyrazole moiety |
| 05/07/2009 | WO2009018065A3 Novel glucokinase activators and methods of using same |
| 05/07/2009 | WO2008032330A3 Improved process for rimonabant |
| 05/07/2009 | US20090118346 Alkyl-Analide Producing Method |
| 05/07/2009 | US20090118345 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 05/07/2009 | US20090118344 Crystalline Chemotherapeutic |
| 05/07/2009 | US20090118335 Acid Secretion Inhibitor |
| 05/07/2009 | CA2703718A1 Inhibitors of histone deacetylase |
| 05/07/2009 | CA2702755A1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 05/06/2009 | EP2054390A1 Indazole derivatives that inhibit trpv1 and uses thereof |
| 05/06/2009 | EP2054388A1 Viral polymerase inhibitors |
| 05/06/2009 | EP2054383A2 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 05/06/2009 | EP1670757B1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | EP1343782B1 Pyrimidineamines as angiogenesis modulators |
| 05/06/2009 | CN101426768A Sulfonamide compounds useful as adg receptor modulators |
| 05/06/2009 | CN101426498A Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof |
| 05/06/2009 | CN101423497A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 05/06/2009 | CN100485536C Organic photoconductive material, and electrophotographic photoreceptor and image forming device using same |
| 05/06/2009 | CN100484944C N4-substited pyrazolyl [4,5-e][1,2,4] thiadiazine derivative and its preparation process and medicine composition |
| 05/05/2009 | US7528260 Method for preparing N-phenylpyrazole-1-carboxamides |
| 05/05/2009 | US7528163 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye |
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders |
| 05/05/2009 | US7528158 Indazolone derivatives useful as 11b-HSD1 inhibitors |
| 05/05/2009 | US7528155 1H-Indazol-3-yl 4-methylpiperidine-1-carboxylate; synergistic mixture with antidiabetic agent, lipid modulators, and other active ingredients for the treatment of disorders of fatty acid metabolism, glucose utilization, and insulin resistance disease |
| 05/05/2009 | CA2436260C Compositions containing a ruthenium(iii) complex and a heterocycle |
| 04/30/2009 | WO2009054925A1 Process for making glucocorticoid receptor ligands |
| 04/30/2009 | WO2009053553A1 Rimonabant 2-methoxyethanol solvate and method for preparing same |
| 04/30/2009 | WO2009053552A1 Rimonabant methanol solvate, method for preparing same and pharmaceutical compositions containing same |
| 04/30/2009 | WO2009053551A1 Rimonabant n,n-dimethylformamide solvate, and method for preparing same |
| 04/30/2009 | WO2009053550A1 Rimonabant n-methylpyrrolidone solvate, method for preparing same and pharmaceutical compositions containing same |
| 04/30/2009 | WO2009053549A1 Rimonabant dmso solvate, method for preparing same and pharmaceutical compositions containing same |
| 04/30/2009 | WO2009053548A1 Rimonabant 1,4-dioxane solvate, method for preparing same and pharmaceutical compositions containing same |
| 04/30/2009 | WO2009053250A1 Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same |
| 04/30/2009 | WO2007016423A3 Method for enantioselective hydrogenation of chromenes |
| 04/30/2009 | US20090111866 Novel Compounds |
| 04/30/2009 | US20090111863 Compounds, Compositions and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies |
| 04/30/2009 | US20090111860 Sulfonamide compounds useful as adg receptor modulators |